Recombinant multi-species ZUP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZUP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein containing zinc finger motifs and a cysteine peptidase domain. The encoded protein functions as a K63-specific de-ubiquitinating enzyme that specifically cleaves long K63-linked polyubiquitin chains in the middle of a chain (i.e. "endo cleavage) rather than by removing the terminal ubiquitin from a chain. This enzyme is thought to be involved in the regulation of DNA repair by cleaving K63-linked ubiquitin chains at repair foci. This protein is related to proteases for the ubiquitin-like modifiers Ufm1 (ubiquitin fold modifier 1) and Atg8/Gabarapl2, but does not have any activity on these modifiers. [provided by RefSeq, Mar 2018]
The Alternative Names of target: 2700019D07Rik,C6orf113,C9H6orf113,DUB,Lys-63-specific deubiquitinase ZUFSP (DUB),RGD1307672,ZUFSP,ZUP1,Zinc finger with UFM1-specific peptidase domain protein,Zinc finger-containing ubiquitin peptidase 1,Zufsp,Zup1

Target products collectionGo to ZUP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T57050-Ag-1/ GM-Tg-hg-T57050-Ag-2 Human ZUP1 protein Human
GM-Tg-rg-T57050-Ag-1/ GM-Tg-rg-T57050-Ag-2 Rat ZUP1 protein Rat
GM-Tg-mg-T57050-Ag-1/ GM-Tg-mg-T57050-Ag-2 Mouse ZUP1 protein Mouse
GM-Tg-cynog-T57050-Ag-1/ GM-Tg-cynog-T57050-Ag-2 Cynomolgus/Rhesus macaque ZUP1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T57050-Ag-1/ GM-Tg-felg-T57050-Ag-2 Feline ZUP1 protein Feline
GM-Tg-cang-T57050-Ag-1/ GM-Tg-cang-T57050-Ag-2 Canine ZUP1 protein Canine
GM-Tg-bovg-T57050-Ag-1/ GM-Tg-bovg-T57050-Ag-2 Bovine ZUP1 protein Bovine
GM-Tg-equg-T57050-Ag-1/ GM-Tg-equg-T57050-Ag-2 Equine ZUP1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T57050-Ag-1/ GM-Tg-hg-T57050-Ag-2; GM-Tg-rg-T57050-Ag-1/ GM-Tg-rg-T57050-Ag-2;
GM-Tg-mg-T57050-Ag-1/ GM-Tg-mg-T57050-Ag-2; GM-Tg-cynog-T57050-Ag-1/ GM-Tg-cynog-T57050-Ag-2;
GM-Tg-felg-T57050-Ag-1/ GM-Tg-felg-T57050-Ag-2; GM-Tg-cang-T57050-Ag-1/ GM-Tg-cang-T57050-Ag-2;
GM-Tg-bovg-T57050-Ag-1/ GM-Tg-bovg-T57050-Ag-2; GM-Tg-equg-T57050-Ag-1/ GM-Tg-equg-T57050-Ag-2
Products Name ZUP1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ZUP1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZUP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.